{"id":"heparin-administration","safety":{"commonSideEffects":[{"rate":"1-10","effect":"Bleeding"},{"rate":"0.5-3","effect":"Heparin-induced thrombocytopenia (HIT)"},{"rate":"0.5-2","effect":"Thrombosis"},{"rate":"1-5","effect":"Injection site reactions"},{"rate":null,"effect":"Osteoporosis (with prolonged use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Heparin binds to and potentiates antithrombin III, a natural inhibitor of coagulation proteases. This complex rapidly inactivates thrombin (Factor IIa) and Factor Xa, preventing the formation of fibrin clots and the propagation of thrombosis. Heparin is used both therapeutically to treat existing clots and prophylactically to prevent clot formation in high-risk patients.","oneSentence":"Heparin is an anticoagulant that inhibits blood clotting by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:22:57.398Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Venous thromboembolism (deep vein thrombosis and pulmonary embolism) treatment and prophylaxis"},{"name":"Acute coronary syndrome"},{"name":"Atrial fibrillation with thromboembolism risk"},{"name":"Thromboprophylaxis in surgical and medical patients"}]},"trialDetails":[{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT07497165","phase":"","title":"Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-11-01","conditions":"Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma","enrollment":48},{"nctId":"NCT07492901","phase":"NA","title":"Impact of Ligament of Marshall Resection on Atrial Fibrillation Occurrence in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-11","conditions":"Post Operative Arrythmia","enrollment":220},{"nctId":"NCT02870738","phase":"PHASE2","title":"Bladder Directed vs. Pelvic Floor Therapy in IC/BPS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corewell Health East","startDate":"2017-04-21","conditions":"Cystitis, Interstitial, Painful Bladder Syndrome","enrollment":128},{"nctId":"NCT06753786","phase":"NA","title":"Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-10-21","conditions":"Venous Thromboembolism, Pulmonary Embolism, Intracerebral Hemorrhage","enrollment":200},{"nctId":"NCT07491393","phase":"PHASE4","title":"Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-04-01","conditions":"Acute Rheumatic Pain","enrollment":24},{"nctId":"NCT07461545","phase":"NA","title":"Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-02-04","conditions":"Cirrhosis, Splenectomy, Venous Thrombosis","enrollment":40},{"nctId":"NCT05597488","phase":"NA","title":"EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-11-01","conditions":"Cirrhosis Portal","enrollment":160},{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07467889","phase":"","title":"Impact of CRRT on Serum Carnitine and Micronutrient Levels","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-01-01","conditions":"Acute Kidney Injury (Nontraumatic), Critical Illness","enrollment":43},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT02675647","phase":"PHASE4","title":"Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2015-12","conditions":"Cardiac Surgery, Cardiopulmonary Bypass, Obese Patients (BMI ≥ 30 kg/m²)","enrollment":60},{"nctId":"NCT04618913","phase":"","title":"Anticoagulation in Patients With Venous Thromboembolism and Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-12-14","conditions":"Neoplasms, Embolism","enrollment":1},{"nctId":"NCT07464808","phase":"NA","title":"Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-28","conditions":"Venous Thromboembolic Event","enrollment":25},{"nctId":"NCT07462182","phase":"NA","title":"Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Aamir Latif","startDate":"2026-04-01","conditions":"Intrauterine Growth Restriction","enrollment":108},{"nctId":"NCT03297281","phase":"NA","title":"Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)","status":"RECRUITING","sponsor":"Clinique Pasteur","startDate":"2017-10-30","conditions":"Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction","enrollment":389},{"nctId":"NCT07454434","phase":"NA","title":"The Effect of Music on Anxiety Levels and Sleep Quality in Patients Who Have a Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Mersin University","startDate":"2026-02-23","conditions":"Sleep Quality, Anxiety","enrollment":64},{"nctId":"NCT02653092","phase":"NA","title":"Reprometabolic Syndrome Mediates Subfertility in Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2016-06","conditions":"Obesity, Infertility, Hypogonadotropic Hypogonadotropism","enrollment":84},{"nctId":"NCT03041805","phase":"","title":"Caprini Score in Venous Surgery: a Prospective Cohort Study","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2017-01-01","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":3000},{"nctId":"NCT07288489","phase":"PHASE3","title":"Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.","status":"NOT_YET_RECRUITING","sponsor":"VarmX B.V.","startDate":"2026-03","conditions":"Blood Loss, Surgical, Coagulation Disorder","enrollment":800},{"nctId":"NCT05286814","phase":"PHASE2","title":"PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-10-24","conditions":"Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Intrahepatic Bile Duct Cancer","enrollment":70},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT05531474","phase":"NA","title":"Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2020-11-02","conditions":"Cardiovascular Complication, Bariatric Surgery Candidate","enrollment":200},{"nctId":"NCT07326215","phase":"NA","title":"A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2025-12-11","conditions":"Acute Respiratory Distress Syndrome, Acute Kidney Injury","enrollment":99},{"nctId":"NCT06604026","phase":"NA","title":"Investigational Study With the BD PosiFlush™ SafeScrub on NADs","status":"RECRUITING","sponsor":"Becton, Dickinson and Company","startDate":"2024-10-22","conditions":"CRBSI - Catheter Related Bloodstream Infection","enrollment":220},{"nctId":"NCT07140211","phase":"PHASE3","title":"Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis","status":"RECRUITING","sponsor":"Marc Blondon","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum","enrollment":9200},{"nctId":"NCT06094920","phase":"PHASE4","title":"Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2024-07-29","conditions":"Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":12},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05890781","phase":"NA","title":"Engineering Immune Organoids to Study Pediatric Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-05-12","conditions":"Brain Tumor, Kidney Tumor, Neuroblastoma","enrollment":108},{"nctId":"NCT07388420","phase":"NA","title":"Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-02","conditions":"Hypertriglyceridemia Induced Acute Pancreatitis","enrollment":40},{"nctId":"NCT07388927","phase":"PHASE4","title":"A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A","status":"NOT_YET_RECRUITING","sponsor":"DKSH Management (Thailand) Limited","startDate":"2026-02","conditions":"Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A, Crow's Feet Lines, Lateral Canthal Lines, LCL","enrollment":48},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT05701917","phase":"NA","title":"DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2023-01-06","conditions":"Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome","enrollment":300},{"nctId":"NCT07388056","phase":"","title":"Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2012-01-01","conditions":"Cancer-associated Thrombosis","enrollment":169},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT06313203","phase":"PHASE2","title":"HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-02-13","conditions":"Intrahepatic Cholangiocarcinoma, Chemotherapy Effect","enrollment":39},{"nctId":"NCT06080074","phase":"PHASE2","title":"Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-04-15","conditions":"Heart Failure, Cardiogenic Shock, Congenital Heart Disease","enrollment":50},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT06981624","phase":"NA","title":"Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion","status":"RECRUITING","sponsor":"Olivier F. Bertrand","startDate":"2025-05-13","conditions":"Radial Artery Occlusion","enrollment":500},{"nctId":"NCT07361783","phase":"NA","title":"Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial","status":"RECRUITING","sponsor":"Chen Jing","startDate":"2025-08-13","conditions":"Primary PCI, ST-elevation Myocardial Infarction (STEMI)","enrollment":6294},{"nctId":"NCT07361679","phase":"PHASE4","title":"LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention","status":"RECRUITING","sponsor":"Alexandra Hospital, Athens, Greece","startDate":"2023-01-18","conditions":"Preeclampsia Severe, Toxemia Of Pregnancy, Preeclampsia","enrollment":100},{"nctId":"NCT06394830","phase":"PHASE2","title":"Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)","status":"RECRUITING","sponsor":"Vaneltix Pharma, Inc.","startDate":"2024-12-13","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":50},{"nctId":"NCT06315530","phase":"PHASE2","title":"Effect of Telitacicept on Antibody Titers in Primary APS Patients","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2023-12-01","conditions":"Antiphospholipid Syndrome (APS)","enrollment":20},{"nctId":"NCT07352358","phase":"PHASE4","title":"Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-30","conditions":"Cerebral Venous Thrombosis","enrollment":72},{"nctId":"NCT04268940","phase":"","title":"Thrombo-Elastography Guided Management of ECMO","status":"COMPLETED","sponsor":"Damian Ratano","startDate":"2020-06-03","conditions":"Extracorporeal Circulation of Blood; Thrombocytopenia","enrollment":61},{"nctId":"NCT07342127","phase":"","title":"Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-02-01","conditions":"Factor V Leiden Heterozygous Mutation, Factor II Heterozygous Mutation, Pregnancy","enrollment":100},{"nctId":"NCT05459818","phase":"","title":"Individual Patient Data Analysis of Viabahn for Peripheral Arterial Disease","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2022-10-12","conditions":"Peripheral Vascular Diseases","enrollment":977},{"nctId":"NCT06937372","phase":"NA","title":"Delivery and Implementation of a Randomised Crossover Trial on Thrombosis","status":"NOT_YET_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2026-08-01","conditions":"Hip Fractures, Venous Thromboembolism (VTE)","enrollment":21194},{"nctId":"NCT00861692","phase":"PHASE2","title":"Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-04","conditions":"Heparin-induced Thrombocytopenia Type II","enrollment":20},{"nctId":"NCT05089227","phase":"PHASE2","title":"Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-02-03","conditions":"Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia","enrollment":72},{"nctId":"NCT05171075","phase":"PHASE3","title":"A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anthos Therapeutics, Inc.","startDate":"2022-09-27","conditions":"Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism","enrollment":417},{"nctId":"NCT07285603","phase":"PHASE1","title":"A Study in Healthy Subjects to Assess the Safety and Tolerability of a 120-hour Continuous Infusion of M6229","status":"COMPLETED","sponsor":"Matisse Pharmaceuticals","startDate":"2024-11-21","conditions":"Healthy Subjects","enrollment":15},{"nctId":"NCT07286409","phase":"NA","title":"Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-01","conditions":"Respiratory Distress Syndrome, Mechanical Ventilation Complication","enrollment":344},{"nctId":"NCT06195540","phase":"PHASE3","title":"RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2024-07-19","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism","enrollment":1424},{"nctId":"NCT05774691","phase":"PHASE4","title":"Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-11-01","conditions":"Aortic Valve Stenosis","enrollment":1000},{"nctId":"NCT07250763","phase":"PHASE4","title":"Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Inova Health Care Services","startDate":"2023-09-20","conditions":"Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation","enrollment":145},{"nctId":"NCT06640114","phase":"NA","title":"Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis","status":"COMPLETED","sponsor":"Efferon JSC","startDate":"2024-10-22","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT02855047","phase":"","title":"The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2005-07","conditions":"Antiphospholipid Syndrome","enrollment":513},{"nctId":"NCT07243080","phase":"PHASE4","title":"Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention","status":"RECRUITING","sponsor":"Mayo Hospital Lahore","startDate":"2025-10-10","conditions":"Deep Venous Thromboses, Laparotomy Patients","enrollment":212},{"nctId":"NCT05684796","phase":"NA","title":"Comparison of Two Pulmonary Embolism Treatments","status":"COMPLETED","sponsor":"Penumbra Inc.","startDate":"2023-11-27","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT05203705","phase":"PHASE2","title":"Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Shanghai Hengrui Pharmaceutical Co., Ltd.","startDate":"2022-03-07","conditions":"Prevention of Venous Thrombosis After TKA","enrollment":64},{"nctId":"NCT06714864","phase":"PHASE4","title":"Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age","status":"RECRUITING","sponsor":"CorMedix","startDate":"2025-07-08","conditions":"Catheter-Related Infections","enrollment":36},{"nctId":"NCT07195955","phase":"NA","title":"Cold Spray for Pain and Ecchymosis After Anticoagulant Prophylaxis in Orthopedic Surgery","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2024-02-01","conditions":"Nursing Care, Cold Application, Pain","enrollment":101},{"nctId":"NCT04617093","phase":"NA","title":"Post-Market Study of Low-flow ECCO2R Using PrismaLung+","status":"COMPLETED","sponsor":"Vantive Health LLC","startDate":"2021-04-30","conditions":"Mild to Moderate Acute Respiratory Distress Syndrome","enrollment":63},{"nctId":"NCT06204549","phase":"NA","title":"Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-05-21","conditions":"Adverse Cardiac Event, Major Adverse Cardiac Events","enrollment":70},{"nctId":"NCT07196358","phase":"NA","title":"Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites","status":"COMPLETED","sponsor":"Dr. Ruth K.M. Pfau Civil Hospital, Karachi","startDate":"2024-08-15","conditions":"Hypertrophic Scarring, Pain, Postoperative, Wound Healing","enrollment":400},{"nctId":"NCT06152250","phase":"NA","title":"Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2023-01-29","conditions":"Liver Diseases","enrollment":60},{"nctId":"NCT07168005","phase":"NA","title":"Informative Video Before LMWH Postpartum - Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum Care, Anxiety","enrollment":160},{"nctId":"NCT06890312","phase":"NA","title":"Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2025-06-05","conditions":"Coronary Angiography, Percutaneous Coronary Intervention, Radial Artery Occlusion","enrollment":550},{"nctId":"NCT06118957","phase":"PHASE2","title":"Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-10-11","conditions":"Thromboembolism","enrollment":64},{"nctId":"NCT05618808","phase":"PHASE2","title":"A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-05-24","conditions":"Venous Thromboembolism","enrollment":373},{"nctId":"NCT03822975","phase":"NA","title":"Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2019-02-14","conditions":"ST Elevation Myocardial Infarction","enrollment":6016},{"nctId":"NCT06215378","phase":"PHASE3","title":"Antagonization of Heparin With Protamine Sulfate After TAVI","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-05-25","conditions":"Aortic Valve Stenosis, Heart Valve Diseases","enrollment":940},{"nctId":"NCT05625932","phase":"PHASE3","title":"TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Galician Research Group on Digestive Tumors","startDate":"2023-03-02","conditions":"Colorectal Cancer Metastatic, Thromboembolism","enrollment":232},{"nctId":"NCT05576766","phase":"NA","title":"Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2025-09","conditions":"Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy, Enhanced Recovery After Surgery (ERAS) Protocol","enrollment":54},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT05011656","phase":"NA","title":"Blood Purification for the Treatment of Pathogen Associated Shock","status":"ACTIVE_NOT_RECRUITING","sponsor":"ExThera Medical Corporation","startDate":"2024-04-19","conditions":"Septic Shock","enrollment":15},{"nctId":"NCT04762992","phase":"PHASE3","title":"LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)","status":"ENROLLING_BY_INVITATION","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2022-07-18","conditions":"Fetal Growth Retardation, Prematurity, Pre-Eclampsia","enrollment":12},{"nctId":"NCT06004674","phase":"PHASE2","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2023-12-26","conditions":"Adverse Pregnancy Outcome","enrollment":20},{"nctId":"NCT04049591","phase":"NA","title":"Higher vs. Lower Dose Heparin for PCI","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2022-03-02","conditions":"Cardiovascular Diseases, Percutaneous Coronary Intervention","enrollment":16000},{"nctId":"NCT05841498","phase":"NA","title":"Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome","status":"COMPLETED","sponsor":"University Medical Center Mainz","startDate":"2023-05-08","conditions":"Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition","enrollment":40},{"nctId":"NCT07083609","phase":"","title":"Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam","status":"RECRUITING","sponsor":"Hieu Trung Dinh","startDate":"2025-07-11","conditions":"Cerebral Venous Thrombosis","enrollment":69},{"nctId":"NCT05484830","phase":"NA","title":"Coagulation in Acute Aortic Dissection","status":"COMPLETED","sponsor":"Ivy susanne Modrau, MD","startDate":"2022-11-01","conditions":"Acute Aortic Dissection, Coagulation Disorder","enrollment":26},{"nctId":"NCT06712004","phase":"PHASE2","title":"A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-02-10","conditions":"Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction","enrollment":40},{"nctId":"NCT05990894","phase":"","title":"Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-07-01","conditions":"Cerebral Venous Thrombosis","enrollment":170},{"nctId":"NCT06013449","phase":"NA","title":"Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03","conditions":"Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome","enrollment":20},{"nctId":"NCT06515730","phase":"PHASE4","title":"Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-04-08","conditions":"Left Ventricular Thrombus, Acute Myocardial Infarction","enrollment":212},{"nctId":"NCT03542279","phase":"NA","title":"CPI Combination Therapy for Autoimmune Encephalitis","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-11-25","conditions":"Autoimmune Encephalitis","enrollment":70},{"nctId":"NCT05035108","phase":"EARLY_PHASE1","title":"The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2021-09-05","conditions":"Hepatoma Resectable","enrollment":10},{"nctId":"NCT03045406","phase":"PHASE3","title":"Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer","status":"COMPLETED","sponsor":"Fadoi Foundation, Italy","startDate":"2017-04-13","conditions":"Venous Thromboembolism","enrollment":1170},{"nctId":"NCT07032025","phase":"EARLY_PHASE1","title":"Mechanical Thrombectomy for Acute Pulmonary Embolism","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-07-01","conditions":"Acute Pulmonary Embolism","enrollment":200},{"nctId":"NCT04997265","phase":"NA","title":"Strategies for Anticoagulation During Venovenous ECMO","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-12","conditions":"Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism","enrollment":26},{"nctId":"NCT04635241","phase":"PHASE2, PHASE3","title":"Inhaled Heparin for Hospitalised COVID-19 Patients","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-06-01","conditions":"Covid19","enrollment":485},{"nctId":"NCT06868823","phase":"","title":"Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation","status":"RECRUITING","sponsor":"University Hospital, Motol","startDate":"2025-05-01","conditions":"Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO), Anticoagulants and Bleeding Disorders","enrollment":40},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT04741464","phase":"NA","title":"Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2021-02-02","conditions":"Deep Vein Thrombosis, Inflammatory Response","enrollment":9},{"nctId":"NCT05634057","phase":"NA","title":"Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis","status":"RECRUITING","sponsor":"Chen Ying","startDate":"2024-01-25","conditions":"Sepsis","enrollment":782}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Heparin administration","genericName":"Heparin administration","companyName":"Anemia Working Group Romania","companyId":"anemia-working-group-romania","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Heparin is an anticoagulant that inhibits blood clotting by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors. Used for Venous thromboembolism (deep vein thrombosis and pulmonary embolism) treatment and prophylaxis, Acute coronary syndrome, Atrial fibrillation with thromboembolism risk.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}